Published in N Engl J Med on May 16, 1996
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs. Ann Rheum Dis (2010) 10.03
A randomized comparative effectiveness study of oral triple therapy versus etanercept plus methotrexate in early aggressive rheumatoid arthritis: the treatment of Early Aggressive Rheumatoid Arthritis Trial. Arthritis Rheum (2012) 4.01
Cyclosporin A monotherapy versus cyclosporin A and methotrexate combination therapy in patients with early rheumatoid arthritis: a double blind randomised placebo controlled trial. Ann Rheum Dis (2003) 2.34
Treatment of rheumatoid arthritis: state of the art 2009. Nat Rev Rheumatol (2009) 1.95
The microbiome and rheumatoid arthritis. Nat Rev Rheumatol (2011) 1.91
Long term efficacy and safety of adalimumab plus methotrexate in patients with rheumatoid arthritis: ARMADA 4 year extended study. Ann Rheum Dis (2005) 1.84
Antibody responses to Porphyromonas gingivalis (P. gingivalis) in subjects with rheumatoid arthritis and periodontitis. Int Immunopharmacol (2008) 1.79
Molecular imaging of rheumatoid arthritis by radiolabelled monoclonal antibodies: new imaging strategies to guide molecular therapies. Eur J Nucl Med Mol Imaging (2009) 1.62
Combination therapy in early rheumatoid arthritis: a randomised, controlled, double blind 52 week clinical trial of sulphasalazine and methotrexate compared with the single components. Ann Rheum Dis (1999) 1.44
Combination DMARD therapy for rheumatoid arthritis: a step closer to the goal. Ann Rheum Dis (1996) 1.44
Regular examinations for toxic maculopathy in long-term chloroquine or hydroxychloroquine users. JAMA Ophthalmol (2014) 1.43
Interleukin-6: a new therapeutic target. Arthritis Res Ther (2006) 1.36
Efficacy and toxicity of methotrexate (MTX) monotherapy versus MTX combination therapy with non-biological disease-modifying antirheumatic drugs in rheumatoid arthritis: a systematic review and meta-analysis. Ann Rheum Dis (2008) 1.32
Efficacy of conventional synthetic disease-modifying antirheumatic drugs, glucocorticoids and tofacitinib: a systematic literature review informing the 2013 update of the EULAR recommendations for management of rheumatoid arthritis. Ann Rheum Dis (2014) 1.31
Are rheumatologists' treatment decisions influenced by patients' age? Rheumatology (Oxford) (2006) 1.15
HLA-DRB1 typing in rheumatoid arthritis: predicting response to specific treatments. Ann Rheum Dis (1998) 1.14
The national database of the German Collaborative Arthritis Centres: II. Treatment of patients with rheumatoid arthritis. Ann Rheum Dis (2001) 1.14
Rheumatology. BMJ (1998) 1.12
Appropriate and effective management of rheumatoid arthritis. Ann Rheum Dis (2004) 1.06
Methotrexate in rheumatoid arthritis: a quarter century of development. Trans Am Clin Climatol Assoc (2013) 1.03
Selection bias in rheumatic disease research. Nat Rev Rheumatol (2014) 1.02
Validation of the methotrexate-first strategy in patients with early, poor-prognosis rheumatoid arthritis: results from a two-year randomized, double-blind trial. Arthritis Rheum (2013) 1.01
Feasibility of tailored treatment based on risk stratification in patients with early rheumatoid arthritis. Arthritis Res Ther (2014) 1.00
Randomised comparison of initial triple DMARD therapy with methotrexate monotherapy in combination with low-dose glucocorticoid bridging therapy; 1-year data of the tREACH trial. Ann Rheum Dis (2014) 0.98
Inflammation predicts accelerated brachial arterial wall changes in patients with recent-onset rheumatoid arthritis. Arthritis Res Ther (2009) 0.96
New therapies for rheumatoid arthritis. Clin Exp Immunol (2005) 0.95
Quantitative gait analysis as a method to assess mechanical hyperalgesia modulated by disease-modifying antirheumatoid drugs in the adjuvant-induced arthritic rat. Arthritis Res Ther (2007) 0.95
Current imaging strategies in rheumatoid arthritis. Am J Nucl Med Mol Imaging (2012) 0.94
Abatacept improves both the physical and mental health of patients with rheumatoid arthritis who have inadequate response to methotrexate treatment. Ann Rheum Dis (2006) 0.93
Use of risk stratification to target therapies in patients with recent onset arthritis; design of a prospective randomized multicenter controlled trial. BMC Musculoskelet Disord (2009) 0.91
Time trends in the characteristics of patients undergoing primary total knee arthroplasty. Arthritis Care Res (Hoboken) (2014) 0.90
Classic disease modifying anti-rheumatic drugs (DMARDs) in combination with infliximab. The Finnish experience. Rheumatol Int (2005) 0.90
Methotrexate: optimizing the efficacy in rheumatoid arthritis. Ther Adv Musculoskelet Dis (2011) 0.88
Dendritic cells and the promise of antigen-specific therapy in rheumatoid arthritis. Arthritis Res Ther (2013) 0.88
Treatment of rheumatoid arthritis with methotrexate alone and in combination with other conventional DMARDs using the T2T strategy. A cohort study. Clin Rheumatol (2014) 0.87
N-of-1 trials of expensive biological therapies: a third way? Arch Intern Med (2008) 0.86
Rheumatoid arthritis: should we shift the focus from "Treat to Target" to "Treat to Work?". Clin Rheumatol (2013) 0.86
Increasing obesity and comorbidity in patients undergoing primary total hip arthroplasty in the U.S.: a 13-year study of time trends. BMC Musculoskelet Disord (2014) 0.86
Combination therapy for rheumatoid arthritis in the era of biologicals. HSS J (2006) 0.86
Efficacy of leflunomide addition in relation to prognostic factors for patients with active early rheumatoid arthritis failing to methotrexate in daily practice. Clin Rheumatol (2011) 0.83
Unmet needs in rheumatoid arthritis. Arthritis Res Ther (2005) 0.83
Cost effectiveness analysis of disease modifying antirheumatic drugs in rheumatoid arthritis. Rheumatol Int (2007) 0.83
Old drugs, old problems: where do we stand in prediction of rheumatoid arthritis responsiveness to methotrexate and other synthetic DMARDs? BMC Med (2013) 0.82
Sustained Remission After Combination Therapy with Rituximab and Etanercept in Two Patients with Rheumatoid Arthritis After TNF Failure: Case Report. Open Rheumatol J (2009) 0.80
Randomized controlled trial design in rheumatoid arthritis: the past decade. Arthritis Res Ther (2009) 0.79
Making smart investment decisions in clinical research. Trials (2015) 0.79
[Methotrexate in rheumatology]. Z Rheumatol (2009) 0.79
Cutaneous abnormalities in rheumatoid arthritis compared with non-inflammatory rheumatic conditions. Ann Rheum Dis (2006) 0.78
Creative trial design in RA: optimizing patient outcomes. Nat Rev Rheumatol (2013) 0.78
Methotrexate revisited: considerations for subcutaneous administration in RA. Clin Rheumatol (2014) 0.78
Rheumatoid arthritis. Triple therapy or etanercept after methotrexate failure in RA? Nat Rev Rheumatol (2013) 0.78
Certolizumab pegol: a new biologic targeting rheumatoid arthritis. Expert Rev Clin Immunol (2010) 0.78
[Combination therapy using methotrexate with DMARDs or biologics--current status]. Z Rheumatol (2011) 0.78
A mass spectrometric investigation of the binding of gold antiarthritic agents and the metabolite [Au(CN)2]- to human serum albumin. J Biol Inorg Chem (2006) 0.77
Cost per responder of TNF-α therapies in Germany. Clin Rheumatol (2013) 0.77
Dilemmas of low dosage glucocorticoid treatment in rheumatoid arthritis: considerations of timing. Ann Rheum Dis (1997) 0.77
Rheumatoid arthritis. BMJ Clin Evid (2007) 0.77
Trajectory of intensive treat-to-target disease modifying drug regimen in an observational study of an early rheumatoid arthritis cohort. BMJ Open (2013) 0.77
Immune Modulation as Adjunctive Therapy for Pneumocystis pneumonia. Interdiscip Perspect Infect Dis (2011) 0.77
Suppression of antibody-mediated arthritis in mice by Fab fragments of the mediating antibodies. Br J Pharmacol (2010) 0.77
Great expectations of modern RA treatment. Ann Rheum Dis (2005) 0.77
Treating early rheumatoid arthritis intensively: current UK practice does not reflect guidelines. Clin Rheumatol (2010) 0.76
Assessment of the treat-to-target strategy in patients with refractory rheumatoid arthritis. A prospective study on efficacy and safety in a Saudi population. Z Rheumatol (2014) 0.76
MMP-3 as a predictor for structural remission in RA patients treated with MTX monotherapy. Arthritis Res Ther (2016) 0.76
Treatment of rheumatoid arthritis. N Engl J Med (1996) 0.75
Positive influence of Methotrexate-Hydroxychloroquine combination on the expression of GM-CSF receptor on neutrophils of synovial fluid in rheumatoid arthritis. Indian J Clin Biochem (2006) 0.75
Cost-effectiveness of adalimumab for rheumatoid arthritis in Germany. Z Rheumatol (2016) 0.75
Combination treatment strategies in early rheumatoid arthritis. Ann Rheum Dis (2005) 0.75
Treatment of rheumatoid arthritis. N Engl J Med (1996) 0.75
Efficacy, safety, and tolerability of abatacept in the management of rheumatoid arthritis. Open Access Rheumatol (2009) 0.75
Improving patient-centred care for rheumatoid arthritis. CMAJ (2016) 0.75
Current and future management approaches for rheumatoid arthritis. Arthritis Res (2002) 0.75
Systematic review and network meta-analysis of the efficacy and safety of tumour necrosis factor inhibitor-methotrexate combination therapy versus triple therapy in rheumatoid arthritis. RMD Open (2017) 0.75
A multi-biomarker disease activity score and the choice of second-line therapy in early rheumatoid arthritis after methotrexate failure. Arthritis Rheumatol (2016) 0.75
Effects of long-term corticosteroid usage on functional disability in patients with early rheumatoid arthritis, regardless of controlled disease activity. Rheumatol Int (2010) 0.75
Drugs for Autoimmune Inflammatory Diseases: From Small Molecule Compounds to Anti-TNF Biologics. Front Pharmacol (2017) 0.75
[Methotrexate therapy in rheumatologic diseases--an update]. Wien Med Wochenschr (2003) 0.75
Efficacy and safety of tacrolimus for myasthenia gravis: a systematic review and meta-analysis. J Neurol (2017) 0.75
Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med (1996) 15.04
Text-based discovery in biomedicine: the architecture of the DAD-system. Proc AMIA Symp (2000) 6.10
T lymphocyte-directed gene therapy for ADA- SCID: initial trial results after 4 years. Science (1995) 3.87
Golimumab, a human antibody to tumour necrosis factor {alpha} given by monthly subcutaneous injections, in active rheumatoid arthritis despite methotrexate therapy: the GO-FORWARD Study. Ann Rheum Dis (2008) 3.42
Delayed biliary duct obstruction after orthotopic liver transplantation. Surgery (1972) 3.26
A complex containing RNA polymerase II, Paf1p, Cdc73p, Hpr1p, and Ccr4p plays a role in protein kinase C signaling. Mol Cell Biol (1999) 2.80
Yeast Rad54 promotes Rad51-dependent homologous DNA pairing via ATP hydrolysis-driven change in DNA double helix conformation. J Biol Chem (1999) 2.47
Treatment of early rheumatoid arthritis with minocycline or placebo: results of a randomized, double-blind, placebo-controlled trial. Arthritis Rheum (1997) 2.41
Selective loss of suppressor cell function in New Zealand mice induced by NTA. J Immunol (1977) 2.38
Genetic requirements for RAD51- and RAD54-independent break-induced replication repair of a chromosomal double-strand break. Mol Cell Biol (2001) 2.32
Immunosuppression, liver injury, and hepatitis in renal, hepatic, and cardiac homograft recipients: with particular reference to the Australia antigen. Ann Surg (1971) 2.14
Tissue distribution and biochemical and functional properties of Tp55 (CD27), a novel T cell differentiation antigen. J Immunol (1987) 1.92
The effects of 2-year treatment with the aminobisphosphonate alendronate on bone metabolism, bone histomorphometry, and bone strength in ovariectomized nonhuman primates. J Clin Invest (1993) 1.84
The contraction of hepatic stellate (Ito) cells stimulated with vasoactive substances. Possible involvement of endothelin 1 and nitric oxide in the regulation of the sinusoidal tonus. Eur J Biochem (1993) 1.80
Giardiasis: association with homosexuality. Ann Intern Med (1978) 1.75
Extended follow-up of total inferior turbinate resection for relief of chronic nasal obstruction. Laryngoscope (1985) 1.73
Structure-function relationships of the adenovirus DNA-binding protein. J Biol Chem (1979) 1.72
The distribution of plasma lipoproteins in middle-aged male runners. Metabolism (1976) 1.69
Internal olefins to linear amines. Science (2002) 1.64
Catalysis in the crystal: synchrotron radiation studies with glycogen phosphorylase b. EMBO J (1987) 1.60
Lack of prognostic value of syncope in patients with Wolff-Parkinson-White syndrome. J Am Coll Cardiol (1991) 1.59
Promotion of Rad51-dependent D-loop formation by yeast recombination factor Rdh54/Tid1. Genes Dev (2000) 1.56
Inhibition of human cytotoxic T lymphocyte activity in vitro by autologous peripheral blood granulocytes. J Immunol (1985) 1.52
Frequency and intensity of crack use as predictors of women's involvement in HIV-related sexual risk behaviors. Drug Alcohol Depend (2000) 1.49
Lack of efficacy of tranexamic acid in thrombocytopenic bleeding. Transfusion (1991) 1.40
Ropivacaine test dose in extradural anaesthesia. Br J Anaesth (1997) 1.39
Isolation of Helicobacter cinaedi from the colon, liver, and mesenteric lymph node of a rhesus monkey with chronic colitis and hepatitis. J Clin Microbiol (2001) 1.31
Sex differences in formation of anti-T-cell antibodies. Nature (1976) 1.30
Requirement for the SRS2 DNA helicase gene in non-homologous end joining in yeast. Nucleic Acids Res (2000) 1.29
Jugular foramen peripheral nerve sheath tumors. Laryngoscope (1989) 1.27
Influenza immunization in systemic lupus eruthematosus. A double-blind trial. Ann Intern Med (1978) 1.26
Acetaldehyde and malondialdehyde react together to generate distinct protein adducts in the liver during long-term ethanol administration. Hepatology (1996) 1.25
Novel Helicobacter species isolated from rhesus monkeys with chronic idiopathic colitis. J Med Microbiol (2001) 1.24
Free healthy breakfasts in primary schools: a cluster randomised controlled trial of a policy intervention in Wales, UK. Public Health Nutr (2010) 1.24
Effect of ethanol infusion on the ultrastructure of human myocardium. Postgrad Med J (1975) 1.23
A cleavage product of the adenovirus DNA binding protein is active in DNA replication in vitro. Virology (1980) 1.21
Hearing rehabilitation using the BAHA bone-anchored hearing aid: results in 40 patients. Otol Neurotol (2001) 1.20
Eicosanoid-mediated contractility of hepatic stellate cells. Biochem J (1992) 1.20
Ribavirin: efficacy in the treatment of murine autoimmune disease. Science (1977) 1.15
Manual laterality in anvil use: wild chimpanzees cracking Strychnos fruits. Laterality (1999) 1.14
HLA-DRB1 typing in rheumatoid arthritis: predicting response to specific treatments. Ann Rheum Dis (1998) 1.14
Health concerns of high school students and teachers' beliefs about student health concerns. Pediatrics (1988) 1.13
Genetic studies in NZB mice. I. Spontaneous autoantibody production. J Exp Med (1978) 1.13
Transvenous biventricular pacing for heart failure: can the obstacles be overcome? Am J Cardiol (1999) 1.13
Treatment of early seropositive rheumatoid arthritis with minocycline: four-year followup of a double-blind, placebo-controlled trial. Arthritis Rheum (1999) 1.10
Treatment of early seropositive rheumatoid arthritis: a two-year, double-blind comparison of minocycline and hydroxychloroquine. Arthritis Rheum (2001) 1.09
The Pacing Therapies for Congestive Heart Failure (PATH-CHF) study: rationale, design, and endpoints of a prospective randomized multicenter study. Am J Cardiol (1999) 1.08
And the debate continues. Can Fam Physician (1998) 1.07
Detection of circulating antibodies against malondialdehyde-acetaldehyde adducts in patients with alcohol-induced liver disease. Hepatology (2000) 1.06
Polypetide chain termination. Purification of the release factors, R1 and R2, from Escherichia coli. J Biol Chem (1971) 1.05
A specific tryptophan in the I-II linker is a key determinant of beta-subunit binding and modulation in Ca(V)2.3 calcium channels. Biophys J (2002) 1.05
Epitope characterization of malondialdehyde-acetaldehyde adducts using an enzyme-linked immunosorbent assay. Chem Res Toxicol (1997) 1.04
Risk factors in postoperative sepsis: significance of preoperative lymphocytopenia. J Surg Res (1979) 1.03
Double parathyroid adenomas. Clinical and biochemical characteristics before and after parathyroidectomy. Ann Surg (1993) 1.03
Role of suppressor T cells in lymphopoietic disorders. Clin Haematol (1977) 1.02
[Familial juvenile glio-neural dystrophy. Acutely beginning progressive encephalopathy with right-side occipitol-parietal focal symptoms and status epilepticus]. Arch Psychiatr Nervenkr (1970) (1969) 1.01
Regulation by prostaglandin E2 of cytokine-elicited nitric oxide synthesis in rat liver macrophages. Biol Chem Hoppe Seyler (1992) 1.01
Association of malondialdehyde-acetaldehyde (MAA) adducted proteins with atherosclerotic-induced vascular inflammatory injury. Atherosclerosis (1998) 1.01
Clinical relevance of stored electrograms for implantable cardioverter-defibrillator (ICD) troubleshooting and understanding of mechanisms for ventricular tachyarrhythmias. Am J Cardiol (1996) 1.00
The fatty acid synthase (FAS) gene and its promoter in Rattus norvegicus. DNA Seq (1992) 1.00
Transplantation of bone marrow-derived mesenchymal stem cells rescue photoreceptor cells in the dystrophic retina of the rhodopsin knockout mouse. Graefes Arch Clin Exp Ophthalmol (2006) 0.99
Retracted Participation of the cytokines interleukin 6, tumor necrosis factor-alpha, and interleukin 1-beta secreted by acute myelogenous leukemia blasts in autocrine and paracrine leukemia growth control. J Clin Invest (1989) 0.99
Prevalence of thyroid disease and abnormal thyroid function test results in patients with systemic lupus erythematosus. Arthritis Rheum (1987) 0.99
Intraoperative electrophysiologic mapping of the ventricles during sinus rhythm in patients with a previous myocardial infarction. Identification of the electrophysiologic substrate of ventricular arrhythmias. Circulation (1982) 0.98
Fatty acid elongation in yeast--biochemical characteristics of the enzyme system and isolation of elongation-defective mutants. Eur J Biochem (1998) 0.98
Adverse experience with methotrexate during 176 weeks of a longterm prospective trial in patients with rheumatoid arthritis. J Rheumatol (1990) 0.98
Studies on levamisole--induced agranulocytosis. Blood (1980) 0.98
Quasi-monoenergetic neutron reference fields in the energy range from thermal to 200 MeV. Radiat Prot Dosimetry (2004) 0.97
Hypoxia-induced thrombocytopenia in mice. J Lab Clin Med (1975) 0.97
Liver transplantation in HBs antigen (HBsAg) carriers. Prevention of hepatitis B virus (HBV) recurrence by passive immunization. J Hepatol (1991) 0.97
Immunofluorescence studies of anti-T cell antibodies and T cells in systemic lupus erythematosus. Selective loss of brightly staining T cells in active disease. Arthritis Rheum (1979) 0.97
Thromboangiitis obliterans (Buerger's disease) and smokeless tobacco. Arthritis Rheum (1987) 0.96
Estrogen induction of very low density apolipoprotein II synthesis, a major avian liver yolk protein, involves the recruitment of hepatocytes. Endocrinology (1986) 0.96
Clozapine, chlorpromazine, and placebo in newly hospitalized, acutely schizophrenic patients: a controlled, double-blind comparison. Arch Gen Psychiatry (1979) 0.96
Sexual abuse during childhood and adolescence as predictors of HIV-related sexual risk during adulthood among female sexual partners of injection drug users. Violence Against Women (1995) 0.95
Use of a simple enzymatic assay for cholesterol analysis in human bile. J Lipid Res (1980) 0.95
Detection of circulating antibodies to malondialdehyde-acetaldehyde adducts in ethanol-fed rats. Gastroenterology (1998) 0.93